BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 9717055)

  • 1. Endothelial function and dysfunction in heart failure.
    Ferrari R; Bachetti T; Agnoletti L; Comini L; Curello S
    Eur Heart J; 1998 Jul; 19 Suppl G():G41-7. PubMed ID: 9717055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
    Hornig B; Arakawa N; Drexler H
    Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelial dysfunction in cardial failure: potential mechanisms].
    Varin R; Mulder P; Richard V; Thuillez C
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():29-34. PubMed ID: 9515111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats.
    Bachetti T; Comini L; Pasini E; Cargnoni A; Curello S; Ferrari R
    J Mol Cell Cardiol; 2001 Mar; 33(3):395-403. PubMed ID: 11181009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular protection: current possibilities and future perspectives.
    Lüscher TF
    Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
    Andreassen AK; Kirkebøen KA
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
    Landmesser U; Drexler H
    J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of endothelium-dependent vasodilator effects of angiotensin-converting enzyme inhibitors: role of bradykinin generation during ACE inhibition.
    Mombouli JV; Vanhoutte PM
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S74-82. PubMed ID: 1282634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in chronic heart failure. Experimental and clinical studies.
    Drexler H; Hayoz D; Münzel T; Just H; Zelis R; Brunner HR
    Arzneimittelforschung; 1994 Mar; 44(3A):455-8. PubMed ID: 8185723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in human disease.
    Drexler H; Hornig B
    J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of nitric oxide in heart failure].
    Le Corvoisier P; Lopes ME; Su J; Hittinger L
    J Soc Biol; 2000; 194(3-4):143-9. PubMed ID: 11324316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
    Zeiher AM; Schächinger V
    Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
    Tousoulis D; Charakida M; Stefanadis C
    Int J Cardiol; 2005 Apr; 100(3):347-53. PubMed ID: 15837076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial function and bradykinin in humans.
    Hornig B; Drexler H
    Drugs; 1997; 54 Suppl 5():42-7. PubMed ID: 9429844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
    Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
    Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and inhibition of converting enzyme.
    Vanhoutte PM
    Eur Heart J; 1998 Sep; 19 Suppl J():J7-15. PubMed ID: 9796835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitric oxide: the endogenous nitrate in the cardiovascular system].
    Tschudi MR; Lüscher TF
    Herz; 1996 Jun; 21 Suppl 1():50-60. PubMed ID: 8767925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.